A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Clinical trial NCT06090539 · RECRUITING
Trial details
- NCT number
- NCT06090539
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-29
- Primary completion
- 2027-10-28
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.